Lipid Nanoparticle (LNP) Characterization Services
Advanced LNP Characterization for Nucleic Acid Delivery Research
ImmunitasBio provides comprehensive lipid nanoparticle (LNP) characterization services to support the development of mRNA, siRNA, plasmid DNA, and gene-editing delivery systems for preclinical and translational research. Our analytical platform evaluates the critical quality attributes of LNP formulations to ensure optimal stability, encapsulation, and cellular delivery.
Lipid Nanoparticle (LNP) Development
Our LNP Characterization Capabilities :
Physicochemical Characterization :
- Particle size, Polydispersity Index (PDI), and zeta potential analysis using Dynamic Light Scattering (DLS)
- Batch consistency and formulation stability assessment
Nucleic Acid Encapsulation :
- Encapsulation efficiency analysis for plasmid DNA, mRNA, siRNA, and other nucleic acid payloads
- Quantitative evaluation of payload loading and retention
In Vitro Delivery Performance :
- LNP transfection efficiency in mammalian cell lines and primary cells
- Cellular uptake and gene expression assessment
Comparative evaluation of delivery platform performance :
- Optimize your lipid nanoparticle formulations with robust analytical characterization and functional validation to accelerate next-generation nucleic acid therapeutics.
